Page last updated: 2024-11-05

trimipramine and Aggressive Systemic Mastocytosis

trimipramine has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Trimipramine: Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.
trimipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)-2-methylpropyl group at the nitrogen atom. It is used as an antidepressant.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klepper, L1
Tronnier, M1

Other Studies

1 other study available for trimipramine and Aggressive Systemic Mastocytosis

ArticleYear
[Multiple fibromas in systemic mastocytosis].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:5

    Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Biopsy; Fibroma; Histocytochemistry; Humans;

2005